C
Viemed Healthcare, Inc. VMD
$8.71 -$0.51-5.53% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Viemed Healthcare, Inc. is a U.S.-based home healthcare company specializing in respiratory care services for patients with chronic respiratory failure and related cardiopulmonary conditions. The company operates primarily within the home medical equipment and services segment of the broader healthcare industry, with a focus on non-invasive ventilation, sleep therapy, and oxygen therapy. Viemed’s core revenue is generated through recurring reimbursement for equipment rental, clinical monitoring, and patient support services, primarily reimbursed by Medicare, Medicaid, and commercial insurers.

Founded in 2010, Viemed evolved from a regional respiratory services provider into a national operator by emphasizing clinician-led care models and high-touch patient management. Its strategic positioning is centered on complex, high-acuity respiratory patients, particularly those with chronic obstructive pulmonary disease (COPD), neuromuscular disorders, and obesity hypoventilation syndrome. The company differentiates itself through intensive clinical oversight, respiratory therapist engagement, and data-driven patient monitoring, which supports improved outcomes and payer alignment.

Business Operations

Viemed conducts substantially all of its operations through its primary operating subsidiary, Viemed Healthcare LLC, and reports results as a single operating segment focused on home-based respiratory care. Revenue is generated through the provision, setup, and ongoing management of ventilators, bilevel positive airway pressure (BiPAP) devices, continuous positive airway pressure (CPAP) devices, oxygen concentrators, and related disposable supplies. These services are bundled with clinical oversight, compliance monitoring, and 24/7 patient support.

Operations are predominantly domestic, with services delivered across multiple U.S. states through a network of branch locations and clinicians. Viemed controls its care delivery model by directly employing respiratory therapists and care coordinators, rather than relying on third-party service providers. The company maintains payer relationships with federal and state programs as well as private insurers, and does not disclose material reliance on joint ventures; publicly available filings indicate no significant international operating subsidiaries.

Strategic Position & Investments

Viemed’s strategic direction emphasizes disciplined organic growth within underserved respiratory patient populations, particularly high-acuity non-invasive ventilation patients. Growth initiatives have included expanding branch density in existing states, entering new U.S. markets, and increasing penetration within referral networks such as pulmonologists, hospitals, and post-acute care providers. The company has historically favored organic expansion over large-scale acquisitions, with capital allocated toward equipment purchases, technology platforms, and clinician hiring.

From an investment perspective, Viemed has focused on enhancing remote monitoring capabilities, data analytics, and workflow automation to support scale while maintaining clinical quality. While the company has completed small, tuck-in acquisitions of patient assets or regional operations in prior years, public disclosures do not indicate any transformational acquisitions or diversified portfolio holdings. Exposure to emerging healthcare trends is primarily tied to the shift toward home-based care and value-based reimbursement models rather than experimental technologies.

Geographic Footprint

Viemed is headquartered in Lafayette, Louisiana, and operates across a broad footprint in the United States, with a presence in the Southeast, Midwest, Southwest, and Western regions. Its branch network supports both urban and rural markets, allowing the company to serve geographically dispersed patient populations with consistent clinical standards. The U.S. market accounts for substantially all reported revenue and operational activity.

The company does not report material operations outside the United States, nor does it disclose significant international investments or foreign subsidiaries in its public filings. As a result, Viemed’s geographic influence is concentrated domestically, with growth driven by deeper market penetration rather than cross-border expansion.

Leadership & Governance

Viemed’s leadership team combines operational, financial, and clinical expertise, with governance oversight provided by a board of directors experienced in healthcare services and capital markets. The leadership philosophy emphasizes clinician-driven decision-making, regulatory compliance, and sustainable growth aligned with patient outcomes and payer requirements.

Key executives include:

  • Casey HoytChief Executive Officer
  • Todd ZehnderChief Financial Officer
  • Patrick McGuireChief Operating Officer
  • Jason TaylorChief Commercial Officer
  • Katherine AndersonChief Compliance Officer

The executive team’s strategic vision centers on expanding access to high-quality home respiratory care while maintaining profitability through operational efficiency and reimbursement discipline.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $172.70
B
AAPL NASDAQ $247.99
B
MSFT NASDAQ $381.87
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $119.02
B
Top Financial Stocks
See All »
B
B
JPM NYSE $286.56
B
V NYSE $301.62
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $53.46
Top Health Care Stocks
See All »
B
LLY NYSE $906.70
B
JNJ NYSE $235.37
B
AMGN NASDAQ $347.80
Top Real Estate Stocks
See All »
B
PLD NYSE $128.01